Your session is about to expire
← Back to Search
Alpha-1 Blocker
Tamsulosin for Urinary Retention
Phase 4
Waitlist Available
Led By Majid Mirzazadeh, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 30 days postoperatively
Awards & highlights
Study Summary
This trial is testing whether tamsulosin can prevent post-operative urinary retention in women undergoing same-day discharge pelvic reconstructive surgery.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 30 days postoperatively
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 30 days postoperatively
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of Participants With Postoperative (Day 0) Urinary Retention
Secondary outcome measures
Incidence of Delayed Urinary Retention
Number Emergency Department (ED) Visits
Patient Level of Satisfaction With Voiding Function
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: TamsulosinExperimental Treatment1 Intervention
Patients in this arm will receive 10 days of 0.4 mg of oral tamsulosin once daily starting 5 days pre-operatively and continuing until all pills are completed.
Group II: PlaceboPlacebo Group1 Intervention
Patients in this arm will receive 10 days of identical-appearing placebo once daily starting 5 days pre-operatively and continuing until all pills are completed.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tamsulosin
2002
Completed Phase 4
~16790
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesLead Sponsor
1,239 Previous Clinical Trials
1,004,179 Total Patients Enrolled
2 Trials studying Urinary Retention
149 Patients Enrolled for Urinary Retention
Majid Mirzazadeh, MDPrincipal InvestigatorWake Forest Health Sciences
1 Previous Clinical Trials
100 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger